Show simple item record

dc.contributor.authorRowland-Jonesa, Sarah L.
dc.contributor.authorPinheiroa, Susana
dc.contributor.authorKaula, Rupert
dc.contributor.authorHansasutaa, Pokrath
dc.contributor.authorGillespiea, Geraldine
dc.contributor.authorDonga, Tao
dc.contributor.authorPlummerb, Francis A.
dc.contributor.authorBwayob, Job B.
dc.contributor.authorFidlerc, Sarah
dc.contributor.authorWeberc, Jonathan
dc.contributor.authorMcMichaela, Andrew
dc.contributor.authorAppaya, Victor
dc.date.accessioned2013-06-28T06:45:39Z
dc.date.available2013-06-28T06:45:39Z
dc.date.issued2001-11
dc.identifier.citationImmunology Lettersen
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/41434
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/11595285
dc.description.abstractCytotoxic T lymphocyte (CTL) responses have been associated with protection from HIV-1 infection in people with a high degree of exposure to HIV and who show no serological evidence of HIV infection (HEPS, highly exposed persistently seronegative). However, it remains unclear how protective CTL responses could apparently develop in a minority of people, whilst the great majority of HIV-infected people make strong CTL responses yet progress to AIDS and death. In this paper we review the data which supports the hypothesis that the quality of the T-cell response, rather than its magnitude, may be an important factor that merits further investigation.Full-size image (15 K) Fig. 1. CD8+ T-cell responses in exposed seronegative individuals may be transient and detected only in relation to recent exposure. Results of sequential ELISpot assays to measure CD8+ T-cell responses to specific HIV peptides selected on the basis of donor HLA types in two exposed seronegative donors from the discordant couple cohort. The strong responses detected in donor U1 at the first point were measured within 3 weeks of an accidental unprotected sexual exposure, but were not seen at subsequent time-points after protected sexual activity was resumed. The responses in donor U2 are seen at only one time-point, possibly in relationship to unprotected oral HIV exposure.en
dc.language.isoenen
dc.relation.ispartofseriesVolume 79, Issues 1–2, 1 November 2001, Pages 15–20;
dc.subjectCTLsen
dc.subjectHIV-1en
dc.subjectTetramersen
dc.subjectPerforinen
dc.subjectCytokineen
dc.subjectCD27en
dc.titleHow important is the ‘quality’ of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?en
dc.typeArticleen
local.publisherDepartment of Medical Microbiology, P.O. Box 19676, University of Nairobi, Nairobi, Kenyaen
local.publisherMRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UKen
local.publisherDepartment of Genito-Urinary Medicine, Imperial College School of Medicine at St. Mary's Hospital, Paddington, London, UKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record